Stay updated on IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial page.

Latest updates to the IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page’s revision indicator was updated to v3.6.3, replacing the previous v3.6.2 to reflect a new page version.SummaryDifference0.0%

- Check23 days agoChange DetectedThe page's revision label now shows v3.6.2, replacing v3.6.0. This indicates an updated page version, typically reflecting minor updates or corrections.SummaryDifference0.0%

- Check37 days agoChange DetectedThe study record gains new guidance and navigation sections to help readers understand the study and how to participate, including a recruitment update indicating enrollment is closed. The Intervention/Treatment header formatting has been changed, and a site revision notice (Revision: v3.6.0) was added.SummaryDifference0.4%

- Check44 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, indicating a newer build of the site rendering. This is a metadata update and does not reflect changes to the study content or data.SummaryDifference0.0%

- Check65 days agoChange DetectedThe page footer revision label was updated from v3.5.3 to v3.5.4, signaling a minor system/UI update to ClinicalTrials.gov. This change does not modify the study data or content visible on the page.SummaryDifference0.0%

- Check80 days agoChange Detected- The revision label on the page updated from v3.5.2 to v3.5.3, indicating a minor version update.SummaryDifference0.0%

Stay in the know with updates to IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial page.